A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology

PURPOSE: While the Trastuzumab for Gastric Cancer (ToGA) trial demonstrated the efficacy and safety of trastuzumab-based chemotherapy in HER2-positive metastatic gastric cancer, the overall survival (OS) benefit was not found in Asian and diffuse-type cancer patients. The aim of the study is to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jun Ho, Kang, Jung Hun, Hwang, In Gyu, Ahn, Hee Kyung, Baek, Hyun Jin, Lee, Soon Il, Lim, Do Hyoung, Won, Young-Woong, Ji, Jun Ho, Kim, Hyo Song, Rha, Sun Young, Oh, Sung Yong, Lee, Kyung Eun, Lim, Taekyu, Maeng, Chi Hoon, Kim, Moon Jin, Kim, Seung Tae, Lee, Jeeyun, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843742/
https://www.ncbi.nlm.nih.gov/pubmed/26323641
http://dx.doi.org/10.4143/crt.2015.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843742/
https://www.ncbi.nlm.nih.gov/pubmed/26323641
http://dx.doi.org/10.4143/crt.2015.155

Ejemplares similares